-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, MXISHy3bN7nr9xT4tzmjYQ2Y7XWT40ai3XDpih8s4XzX+cNX8ccoYigmjFubAlP/ Hvt9W1+zROPXwAiQzQvZPA== 0001193125-10-086733.txt : 20100618 0001193125-10-086733.hdr.sgml : 20100618 20100419165743 ACCESSION NUMBER: 0001193125-10-086733 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100419 FILER: COMPANY DATA: COMPANY CONFORMED NAME: International Stem Cell CORP CENTRAL INDEX KEY: 0001355790 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204494098 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 2595 JASON COURT CITY: OCEANSIDE STATE: CA ZIP: 92056 BUSINESS PHONE: 760-940-6383 MAIL ADDRESS: STREET 1: 2595 JASON COURT CITY: OCEANSIDE STATE: CA ZIP: 92056 FORMER COMPANY: FORMER CONFORMED NAME: BTHC III INC. DATE OF NAME CHANGE: 20060310 CORRESP 1 filename1.htm Acceleration Request

International Stem Cell Corporation

2595 Jason Court

Oceanside, California 92056

April 19, 2010

VIA EDGAR

Securities and Exchange Commission

100 F Street, NE

Washington, D.C. 20549

Attn: Michael Rosenthall

 

  Re: International Stem Cell Corporation

Registration Statement on Form S-1 (File No. 333-164540)

Ladies and Gentlemen:

International Stem Cell Corporation (the “Company”) hereby requests that the Commission take appropriate action to make the above-captioned Registration Statement effective at 4:00 p.m. Eastern Time, on Wednesday, April 21, 2010, or as soon thereafter as practicable. The Company acknowledges that:

 

  •  

should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

  •  

the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

  •  

the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance.

 

Sincerely,

/s/ Ray Wood

Ray Wood
Chief Financial Officer

cc: Douglas Rein

-----END PRIVACY-ENHANCED MESSAGE-----